Learning Objectives:
At the conclusion of this activity participants will be able to:
1. Understand the epidemiology, presentation and work up of a patient with kidney cancer
2. Understand considerations regarding oncologic treatment of older adults with kidney cancer
3. Be able to outline general treatment paradigms for localized and metastatic kidney cancer and the toxicity associated with targeted and immune therapy
Presenter:
Gretchen Gignac, MD, Presenter, has no relevant financial relationships to disclose.
Faculty member does not plan on discussing unlabeled/investigational uses of a commercial product.
- 1.00 AMA PRA Category 1 Credit™
Boston University Chobanian & Avedisian School of Medicine designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 0.00 MA Opioid Education Statement
- 1.00 MA Risk Management
- 1.00 Participation

Facebook
X
LinkedIn
Forward